Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Influenza, Human × Fluzone High-Dose × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Influenza, Human 1

Interventions

Influenza Vaccines 5 trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine 2 Vaccines 2 thymoglobulin 1 fludarabine 1 baloxavir 1 Rituximab 1 Oseltamivir 1 Nivolumab 1 Melphalan 1 Levetiracetam 1 Ipilimumab 1 Fluzone High-Dose 1 Cyclophosphamide 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01666782 2016-06-24

IMMUNE

Rochester General Hospital

Phase 2 Completed

105 enrolled 10 charts

Influenza, Human, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡